BYRN Form 144: 40,000 common shares proposed sale on NASDAQ

Rhea-AI Filing Summary

Byrna Technologies, Inc. (BYRN) filed a Form 144 notifying a proposed sale of 40,000 common shares by an insider. The shares are scheduled for sale on 10/10/2025 through Raymond James & Associates on NASDAQ with an aggregate market value of $1,193,994.05. The shares were acquired as restricted stock on 01/13/2017 as compensation from the issuer and were fully paid in cash at acquisition. There were 22,725,515 shares outstanding at the time the form reports.

The filer reports no sales in the prior three months and affirms they are not aware of undisclosed material adverse information. This notice documents an intended insider sale and the acquisition origin (compensation) and does not disclose any change in company operations or financial results.

Positive

• Insider used previously issued restricted stock (acquired 01/13/2017) rather than newly issued shares
• No sales reported in the prior three months, indicating no recent insider liquidation

Negative

• Insider plans to sell 40,000 shares for an aggregate of $1,193,994.05, which could exert modest downward pressure on the stock around 10/10/2025

Insights

Equity Capital Markets Analyst

Insider plans to sell ~0.18% of outstanding shares for roughly $1.19M on 10/10/2025.

The filing shows an insider plans to sell 40,000 common shares acquired as restricted stock on 01/13/2017, routed through Raymond James & Associates. With 22,725,515 shares outstanding, the sale represents about 0.18% of the share count and is listed at an aggregate market value of $1,193,994.05.

This is a routine Rule 144 notice documenting a planned sale; its near-term market impact is likely limited given the small percentage of outstanding shares. Watch the actual execution on or shortly after 10/10/2025 for any price pressure or larger follow-on filings that might indicate additional insider selling.

Corporate Governance Specialist

Sale arises from previously issued restricted stock, not a new issuance or transfer.

The securities were acquired as restricted stock as compensation from the issuer and were paid in cash on 01/13/2017, which indicates the sale uses vested compensation holdings rather than newly granted shares. The filer affirms no undisclosed material adverse information exists as part of the certification on the form.

Investors should note the certification and the absence of reported sales in the prior three months; any subsequent disclosure about material developments before 10/10/2025 would change the filing's assurance.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Raymond James & Associates 880 Carillon Parkway St. Petersburg FL 33716	40000	1193994.05	22725515	10/10/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/13/2017	Restricted stock as compensation	Issuer			40000	01/13/2017	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does BYRN's Form 144 announce?

It notifies a proposed insider sale of 40,000 common shares scheduled for 10/10/2025 through Raymond James & Associates on NASDAQ with aggregate value $1,193,994.05.

How were the shares being sold acquired?

The shares were acquired as restricted stock issued as compensation on 01/13/2017 and were paid in cash at acquisition.

What percentage of BYRN's outstanding shares does the sale represent?

The sale of 40,000 shares versus 22,725,515 outstanding represents approximately 0.18% of the share count.

Did the filer report other recent sales?

No. The form states "Nothing to Report" for securities sold during the past three months.

Does the filing indicate any undisclosed material information?

The filer signed a representation that they do not know any material adverse information regarding the issuer that has not been publicly disclosed.